MENU
+Compare
LAB
Stock ticker: NASDAQ
AS OF
Apr 25 closing price
Price
$1.16
Change
-$0.07 (-5.69%)
Capitalization
1.04B

LAB Standard BioTools Forecast, Technical & Fundamental Analysis

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster... Show more

LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LAB with price predictions
Apr 25, 2025

LAB in upward trend: 10-day moving average broke above 50-day moving average on April 24, 2025

The 10-day moving average for LAB crossed bullishly above the 50-day moving average on April 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on LAB as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LAB advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where LAB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

LAB moved below its 50-day moving average on April 25, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LAB broke above its upper Bollinger Band on April 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.869) is normal, around the industry mean (10.413). P/E Ratio (0.000) is within average values for comparable stocks, (81.243). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.010) is also within normal values, averaging (41.902).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. LAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LAB is expected to report earnings to fall 38.89% to -5 cents per share on May 06

Standard BioTools LAB Stock Earnings Reports
Q1'25
Est.
$-0.05
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.17
The last earnings report on February 26 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 710.84K shares outstanding, the current market capitalization sits at 1.04B.
A.I. Advisor
published General Information

General Information

a manufacturer of integrated fluidic circuit systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2 Tower Place
Phone
+1 650 266-6000
Employees
539
Web
https://www.standardbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BTECX11.980.22
+1.87%
Baron Technology Institutional
NOSIX56.030.41
+0.74%
Northern Stock Index
GTTRX27.43-0.05
-0.18%
Goldman Sachs Small Cp Val Insghts R
SINOX36.08-0.10
-0.28%
ClearBridge Large Cap Value C
FSCCX28.92-0.09
-0.31%
Nuveen Small Cap Value I

LAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LAB has been loosely correlated with CERS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LAB jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LAB
1D Price
Change %
LAB100%
-5.69%
CERS - LAB
50%
Loosely correlated
-0.74%
PACB - LAB
46%
Loosely correlated
-4.39%
ATEC - LAB
45%
Loosely correlated
+0.96%
SIBN - LAB
43%
Loosely correlated
+0.14%
MXCT - LAB
41%
Loosely correlated
+1.41%
More